<code id='D31B42999C'></code><style id='D31B42999C'></style>

<acronym id='D31B42999C'></acronym>

<center id='D31B42999C'><center id='D31B42999C'><tfoot id='D31B42999C'></tfoot></center><abbr id='D31B42999C'><dir id='D31B42999C'><tfoot id='D31B42999C'></tfoot><noframes id='D31B42999C'>

<optgroup id='D31B42999C'><strike id='D31B42999C'><sup id='D31B42999C'></sup></strike><code id='D31B42999C'></code></optgroup>

<b id='D31B42999C'><label id='D31B42999C'><select id='D31B42999C'><dt id='D31B42999C'><span id='D31B42999C'></span></dt></select></label></b><u id='D31B42999C'></u>

~~<i id='D31B42999C'><strike id='D31B42999C'><tt id='D31B42999C'><pre id='D31B42999C'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

Wikipedia

author：entertainment 2025-09-29 13:40:14 Page View：589

Bruce Broussard. -- health business coverage from STAT — Humana CEO Bruce Broussard Jason DeCrow/AP

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

advertisement

Humana’s stock fell by more than 2% on the news Wednesday morning.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biogen shutters digital health group, ends Apple study, in cost cutting move
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

comprehensive

How one medical school became remarkably diverse

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Gilead might be held responsible for not developing a drug

Gilead might be held responsible for not developing a drug

JustinSullivan/GettyImagesTheassaultonthedevelopmentofnewlifesavingtherapiescontinuesapace.Recently,

Moonlake's readout produced a cash windfall. Risks remain

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Biden report: The neurospychology of memory and aging

PresidentBidenEvanVucci/APWhatistherelationshipbetweenaging,memoryloss,andoverallcognition?That’sama

read more